Appendices

• Appendix A:
  • Clinical Laboratory Evaluation Program
  • Limited Testing Registration and Instruction
• Appendix B: Biohazard Safety/Universal Precautions
• Appendix C: Subpart 58-8: Human Immunodeficiency Virus (HIV) Testing (PDF, 274 KB, 3pgs)
• Appendix D: Food and Drug Administration (FDA) Sales Restrictions
• Appendix E: Proficiency Testing
• Appendix F: Additional Information Available on CLIA Waived Rapid Tests